Snehal Shah
Hoofd Techniek/Wetenschap/O&O bij OCULIS HOLDING AG
Profiel
Snehal Shah is currently the President-Research & Development at Oculis Holding AG.
Previously, Dr. Shah worked as a Member-Hisamitsu Group at Noven Pharmaceuticals, Inc. from 2012 to 2017.
Dr. Shah also held the position of SVP, Chief Regulatory & Product Strategy Officer at IVERIC bio, Inc. Dr. Shah holds a doctorate degree from the University of Kansas and an undergraduate degree from Rutgers University- Newark.
Actieve functies van Snehal Shah
Bedrijven | Functie | Begin |
---|---|---|
OCULIS HOLDING AG | Hoofd Techniek/Wetenschap/O&O | 10-04-2024 |
Eerdere bekende functies van Snehal Shah
Bedrijven | Functie | Einde |
---|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | 01-01-2017 |
IVERIC BIO, INC. | Algemeen Adviseur | - |
Opleiding van Snehal Shah
Rutgers University- Newark | Undergraduate Degree |
University of Kansas | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OCULIS HOLDING AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |